Harvard Bioscience, Inc. - Common Stock (HBIO)

Harvard Bioscience (HBIO) Earnings Transcript

Harvard Bioscience (HBIO) posted mixed Q3 2025 results, beating on revenue but missing on EPS. Despite the miss, the stock surged as investors focus on strong order growth and a positive restructuring outlook.

In today's session, these stocks are experiencing unusual volume.

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Harvard Bioscience (HBIO) reported mixed Q2 2025 results, missing revenue estimates but matching EPS. Improved cash flow and cost control offset weak sales, with stock up 18.7% pre-earnings.

Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.

Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.